iKang Healthcare Group, Inc.
KANG
KANG was delisted on the 18th of January, 2019.
52 hedge funds and large institutions have $240M invested in iKang Healthcare Group, Inc. in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 7 closing their positions.
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
5% less funds holding
Funds holding: 55 → 52 (-3)
16% less capital invested
Capital invested by funds: $285M → $240M (-$45.7M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
84% less call options, than puts
Call options by funds: $2.85M | Put options by funds: $17.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
+$11.6M |
| 2 |
First Manhattan
New York
|
+$7.6M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$3.66M |
| 4 |
GP
GLG Partners
London,
United Kingdom
|
+$3.41M |
| 5 |
Millennium Management
New York
|
+$2.81M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASI
All-Stars Investment
Hong Kong
|
-$14M |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$10.4M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$8.59M |
| 4 |
EPM
Equitec Proprietary Markets
Chicago,
Illinois
|
-$1.93M |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
-$1.74M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
BNP Paribas Financial Markets
Paris,
France
| $61 | – | – | – |
|
|
ASI
52
All-Stars Investment
Hong Kong
| – | -$14M | -959,864 | Closed |
|
|
PPA
53
Parametric Portfolio Associates
Seattle,
Washington
| – | -$759K | -51,959 | Closed |
|
|
PRCM
54
Pine River Capital Management
Minnetonka,
Minnesota
| – | -$604K | -41,356 | Closed |
|
|
DTL
55
Dynamic Technology Lab
Singapore
| – | -$223K | -15,270 | Closed |
|
56
D.E. Shaw & Co
New York
| – | -$186K | -12,765 | Closed |
|
|
AG
57
Aperio Group
Sausalito,
California
| – | -$149K | -10,196 | Closed |
|
58
UBS Group
Zurich,
Switzerland
| – | -$17K | -1,135 | Closed |
|
|
AIM
59
Acrospire Investment Management
Chicago,
Illinois
| – | -$11.6K | -799 | -100% |
|
KANG Hedge Fund Activity: Q2 2017 in Review
52 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in iKang Healthcare Group, Inc. (KANG) for Q2 2017, worth a combined $240M — down 16% from $285M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of KANG and 4 opened new positions — a net loss of 3 holders — while 14 trimmed existing stakes and 20 added.
The largest buyer was Walleye Trading, adding an estimated $11.6M. The largest seller was All-Stars Investment, exiting entirely with an estimated $14M sold.
- 52 institutional investors held iKang Healthcare Group, Inc. (KANG) as of Q2 2017, down from 55 in Q1 2017.
- Funds reported $240M of iKang Healthcare Group, Inc. stock for Q2 2017, down 16% quarter-over-quarter.
- 4 funds opened new iKang Healthcare Group, Inc. positions in Q2 2017 and 7 closed out, a net change of -3 holders.
- The largest iKang Healthcare Group, Inc. buyer in Q2 2017 was Walleye Trading, an estimated $11.6M added.
- The largest iKang Healthcare Group, Inc. seller in Q2 2017 was All-Stars Investment, an estimated $14M sold.
Based on aggregated 13F filings for Q2 2017.